Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 17/20 | 0.51 |
| ▸ | MPEG1 | Q2M385 | 11/20 | 0.51 |
| ▸ | XIAP | P98170 | 3/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | PTGES | O14684 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27904845 | 0.92 | ALOX5 (0.62) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL5554116 | 0.92 | ALOX5 (0.62) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL7866839 | 0.84 | ACHE (0.47) | ALOX5MPEG1XIAPGPR84KDM4E | |
| Butylated Hydroxytoluene SCHEMBL9706618 | 0.81 | SMN1; SMN2 (0.49) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL10772074 | 0.78 | XIAP (0.54) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL28655350 | 0.78 | ACHE (0.55) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL27487222 | 0.75 | ACHE (0.40) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL1020312 | 0.75 | ALOX5 (0.65) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL19840669 | 0.75 | ACHE (0.37) | ALOX5MPEG1XIAPGPR84KDM4E | |
| Hydrochloric Acid SCHEMBL28922225 | 0.74 | ACHE (0.57) | ALOX5MPEG1XIAPGPR84KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310413-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING A MALT1 INHIBITOR AND A MIXTURE OF POLYETHYLENE GLYCOL WITH A FATTY ACID | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-05 | — | — | US | claimed |
| US-20230301924-A1 | PHARMACEUTICAL FORMULATION | Janssen Pharmaceuticals, Inc. | 2023-09-28 | — | — | US | claimed |
| EP-4240334-A1 | PHARMACEUTICAL FORMULATION | Janssen Pharmaceuticals, Inc. (US) | 2023-09-13 | — | — | EP | claimed |
| EP-4199911-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING A MALT1 INHIBITOR AND A MIXTURE OF POLYETHYLENE GLYCOL WITH A FATTY ACID | JANSSEN Pharmaceutica NV (BE) | 2023-06-28 | — | — | EP | claimed |
| US-20220175760-A1 | PHARMACEUTICAL FORMULATIONS | JANSSEN PHARMACEUTICA NV (BE) | 2022-06-09 | — | — | US | claimed |
| WO-2022094817-A1 | PHARMACEUTICAL FORMULATION | Janssen Pharmaceuticals, Inc. (US) | 2022-05-12 | — | — | WO | claimed |
| WO-2022095912-A1 | PHARMACEUTICAL FORMULATION | Janssen Pharmaceuticals, Inc. (US) | 2022-05-12 | — | — | WO | claimed |
| WO-2022037661-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING A MALT1 INHIBITOR AND A MIXTURE OF POLYETHYLENE GLYCOL WITH A FATTY ACID | JANSSEN PHARMACEUTICA NV (BE) | 2022-02-24 | — | — | WO | claimed |
| EP-3927324-A1 | PHARMACEUTICAL FORMULATIONS | Janssen Pharmaceutica NV (BE) | 2021-12-29 | — | — | EP | claimed |
| US-11191276-B2 | Solid formulations suitable for oilfield applications | RHODIA OPERATIONS (FR) | 2021-12-07 | — | — | US | claimed |
| US-5650185-A | FOOD FLAVORS FOR OILS | ACH FOOD COMPANIES, INC. | 1997-07-22 | — | — | US | claimed |
| EP-0607272-B1 | NON-AEROSOL, UNIFORM SPRAY DISPERSION SYSTEM FOR OIL-BASED PRODUCTS | PAUL LEONARD (US) | 1997-03-19 | — | — | EP | claimed |
| US-5455055-A | A food dispenser comprising a housing for holding the food product, a high compression pump to distribute repeatedly, consistently | ACH FOOD COMPANIES, INC. | 1995-10-03 | — | — | US | claimed |
| EP-0607272-A4 | NON-AEROSOL, UNIFORM SPRAY DISPERSION SYSTEM FOR OIL-BASED PRODUCTS. | STOLTZ EDWIN I (US) | 1995-02-22 | — | — | EP | claimed |
| EP-0607272-A1 | NON-AEROSOL, UNIFORM SPRAY DISPERSION SYSTEM FOR OIL-BASED PRODUCTS. | STOLTZ EDWIN I (US) | 1994-07-27 | — | — | EP | claimed |
| WO-1993006749-A1 | NON-AEROSOL, UNIFORM SPRAY DISPERSION SYSTEM FOR OIL-BASED PRODUCTS | STOLTZ EDWIN I (US) | 1993-04-15 | — | — | WO | claimed |
| EP-0202512-B1 | NICOTINE DISPENSER WITH POLYMERIC RESERVOIR OF NICOTINE | Kabi Pharmacia AB (SE) | 1992-06-17 | — | — | EP | claimed |
| US-4761296-A | DEFATTING AND IMPREGNATION WITH VEGETABLE OILS | NABISCO BRANDS, INC. (US) | 1988-08-02 | — | — | US | claimed |
| US-4736755-A | POLYOLEFINS OR POLYOLEFINDIENES, ESPECIALLY POLYETHYLENE AND POLYPROPYLENE | ADVANCED TOBACCO PRODUCTS (US) | 1988-04-12 | — | — | US | claimed |
| EP-0169088-A2 | Crackers having stabilized sunflower seeds | NABISCO BRANDS, Inc. (US) | 1986-01-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310413-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING A MALT1 INHIBITOR AND A MIXTURE OF POLYETHYLENE GLYCOL WITH A FATTY ACID | MALT1, MGAM, MGLL | ALOX5 429/4885MPEG1 193/4885XIAP 588/4885 |
| US-20230301924-A1 | PHARMACEUTICAL FORMULATION | TTPA, PTGES, HMGCR | ALOX5 318/4885MPEG1 1157/4885XIAP 2807/4885 |
| US-20220175760-A1 | PHARMACEUTICAL FORMULATIONS | TREH, F12, CEL | ALOX5 1440/4885MPEG1 2689/4885XIAP 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.